Drugs / sodium nucleinate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06209229 | May 2022 → May 2023 | non-small cell lung carcinoma | MIPO Clinic | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | sodium nucleinate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06209229 ↗ |